Inhibition Of PI3K/mTOR Overcomes Nilotinib Resistance In BCR-ABL1 Positive Leukemia Cells

被引：0
|
作者：
Ding, Jie
Romani, Julia
Zaborski, Margarete
MacLeod, Roderick A. F.
Nagel, Stefan
Drexler, Hans G.
Quentmeier, Hilmar
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.4906.4906
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4906
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Adaptive resistance of patient-derived ovarian cancer cells to PI3K/mTOR inhibition
    Zervantonakis, Ioannis
    Chen, Hsing-Yu
    Muranen, Taru
    Liu, Joyce
    Drapkin, Ronny
    Matulonis, Ursula
    Brugge, Joan
    CLINICAL CANCER RESEARCH, 2015, 21
  • [32] Prognostic Value of BCR-ABL1 Transcript Type in Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Breccia, Massimo
    Stagno, Fabio
    D'Adda, Mariella
    Levato, Luciano
    Carella, Angelo Michele
    Martino, Bruno
    Tiribelli, Mario
    Fava, Carmen
    Binotto, Gianni
    Avanzini, Paolo
    Bocchia, Monica
    Bergamaschi, Micaela
    Rossi, Antonella Russo
    Cavazzini, Francesco
    Abruzzese, Elisabetta
    Soverini, Simona
    Alimena, Giuliana
    Cavo, Michele
    Martinelli, Giovanni
    Pane, Fabrizio
    Saglio, Giuseppe
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2016, 128 (22)
  • [33] Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia
    Zhanglin Zhang
    Zhiwei Chen
    Mei Jiang
    Shuyuan Liu
    Yang Guo
    Lagen Wan
    Fei Li
    BMC Cancer, 19
  • [34] Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells
    Than, Hein
    Pomicter, Anthony D.
    Yan, Dongqing
    Beaver, Larry P.
    Eiring, Anna M.
    Heaton, William L.
    Senina, Anna
    Clair, Phillip M.
    Shacham, Sharon
    Mason, Clinton C.
    O'Hare, Thomas
    Deininger, Michael W.
    LEUKEMIA, 2020, 34 (06) : 1679 - 1683
  • [35] Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia
    Zhang, Zhanglin
    Chen, Zhiwei
    Jiang, Mei
    Liu, Shuyuan
    Guo, Yang
    Wan, Lagen
    Li, Fei
    BMC CANCER, 2019, 19 (01)
  • [36] Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells
    Hein Than
    Anthony D. Pomicter
    Dongqing Yan
    Larry P. Beaver
    Anna M. Eiring
    William L. Heaton
    Anna Senina
    Phillip M. Clair
    Sharon Shacham
    Clinton C. Mason
    Thomas O’ Hare
    Michael W. Deininger
    Leukemia, 2020, 34 : 1679 - 1683
  • [37] Inhibition of Autophagy in Combination with Ponatinib or Dual PI3K/mTOR Inhibition to Improve Treatment Response for Both Bcr-Abl Dependent and Independent Mechanisms of TKI-Resistance in CML
    Helgason, G. Vignir
    Allan, Elaine K.
    Mariani, Samanta
    Mukhopadhyay, Arunima
    Karvela, Maria
    Galavotti, Sara
    Audia, Alessandra
    Hamilton, Ashley
    Nicolini, Franck E.
    Druker, Brian J.
    Salomoni, Paolo
    Calabretta, Bruno
    Holyoake, Tessa L.
    BLOOD, 2012, 120 (21)
  • [38] Unbiased screening reveals that blocking exportin 1 overcomes resistance to PI3Kα inhibition in breast cancer
    Xue-Ling Liu
    Bo-Bo Wang
    Yi Wang
    Yu-Xiang Wang
    Chun-hao Yang
    Cun Tan
    Xi Zhang
    Qiao-jun He
    Jian Ding
    Ling-Hua Meng
    Signal Transduction and Targeted Therapy, 4
  • [39] Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species
    Kim, JH
    Chu, SC
    Gramlich, JL
    Pride, YB
    Babendreier, E
    Chauhan, D
    Salgia, R
    Podar, K
    Griffin, JD
    Sattler, M
    BLOOD, 2005, 105 (04) : 1717 - 1723
  • [40] Unbiased screening reveals that blocking exportin 1 overcomes resistance to PI3Kα inhibition in breast cancer
    Liu, Xue-Ling
    Wang, Bo-Bo
    Wang, Yi
    Wang, Yu-Xiang
    Yang, Chun-hao
    Tan, Cun
    Zhang, Xi
    He, Qiao-jun
    Ding, Jian
    Meng, Ling-Hua
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
12345